Relief srl

Our mission is to reinvent bladder drainage with safer and more dignified devices. Vesiflo is developing the Guardian™ Program, a remote monitoring and clinical information system designed to provide superior care of community-dwelling women with chronic urinary retention. Our major product to date is the inFlow™ urinary prosthesis for women with chronic urinary retention (CUR). Connolly is a career entrepreneur who has founded and operated five medical device companies, all of which manufactured proprietary devices. Connolly was Founder/CEO of SRS Medical, a manufacturer of urodynamics systems and other bladder-related technologies now owned by Schooner Capital of Boston MA. Connolly was Founder/CEO of Fasstech, Inc., a manufacturer of medical instruments that was merged into SRS Medical. Susan Robinson is a full-time consultant to the company who has over 20 years of experience in the biotech industry, most recently as CEO and a Director of Targeted Genetics Corporation, a publicly traded biotech company. Sullivan is consulting as CFO while serving as the full-time CFO for a Seattle pharmaceutical business.

Inspired by the real-world challenges facing urinary incontinence patients, ProvenMed was founded to develop and produce effective, innovative products that bring relief to patients the world over. Providing a complete development to manufacture process, ProvenMed have developed the revolutionary ActivGo® for men, a product developed entirely from the experience of a friend suffering from the condition. It is the first urinary incontinence wearable device of its kind, developed completely from the patient’s perspective, not from an engineer’s view. We strive to be a trusted and leading innovator of life-transforming smart medical wearable devices. Soon we would be coming with a women’s product, but for now our product is only for men. The product is really Great one but try to reduce the cost for shipping to United kingdom.

We are currently focused on three therapeutic areas where we can best leverage our internal know-how and assets: rare metabolic disorders, rare pulmonary diseases, and rare connective tissue disorders, with particular emphasis on conditions with dermatological manifestations. Relief Therapeutics is a Swiss, commercial - stage biopharmaceutical company, developing and commercializing novel, patent - protect products in selected specialty, rare and ultra-rare diseases. In addition, Relief Therapeutics is commercializing several legacy products via licensing and distribution partners. Founded in 2013 by three former Merck employees, Relief Therapeutics embarked on a mission to develop atexakin alfa – a human recombinant version of interleukin-6 aimed at treating peripheral neuropathy. Prior to joining Relief, Jeremy provided financial consulting and controlling services to companies in various industries. Country Lead and is responsible for leading company’s U.S. Raghuram (Ram) Selvaraju, Ph.D., MBA, is a Managing Director and Senior Healthcare Analyst in the Equity Research Division of H.C. Patrice Jean is the Chair of the Life Sciences Practice at Hughes Hubbard & Reed, an international law firm based in New York City.

We are on a mission to help millions of people restore their pelvic floor and treat bladder weakness, giving them the confidence and control they need to live an active life. We develop and manufacture medical device-quality pelvic floor muscle strengthening products — all backed by strong clinical evidence and subjected to controlled trials. We are at the leading edge of technological developments in muscle rehabilitation and conditioning, pioneering clinically proven pelvic floor health solutions. INNOVO® offers the only clinically-proven, wearable and truly non-invasive solution for stress urinary incontinence (SUI). Using unique multipath™ technology, INNOVO targets the weakened pelvic floor muscles, delivering 180 perfect and complete pelvic floor contractions over each 30-minute session. Recommended by 98% of physicians and 90% of users, INNOVO is the perfect solution for treating stress urinary incontinence. Thousands of healthcare providers and customers across the world rely on INNOVO® to improve the lives of those with pelvic floor issues. Since launching in the European market of March 2016, INNOVO® has become the leading choice for a safe, effective, home-based treatment targeting the causes — not just the symptoms — of bladder weakness.

The product was named as “PILES RELIEF” and it is based on cryotechnology. Rana Hospital is the premium institute for the treatment of anorectal disease. For a doctor, there is a limitation that he can perform a certain number of procedures within in a day. General Medical Systems has now finally achieved its mission by developing a home care solution which can cure Piles & Fissure without Surgery in the comfort of your home in just 7 minutes. It is the world’s fastest solution for the treatment of Piles.

Ingenion Medical Limited (“Ingenion” or the “Company”) is a privately-held, medical device company headquartered in the UK. The Company specializes in creating innovative, clinically relevant, and cost effective solutions to problems of urinary flow and control.